Pring Turner Capital Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $683K | Hold |
6,485
| – | – | 0.41% | 44 |
|
|
2025
Q4 | $683K | Hold |
6,485
| – | – | 0.42% | 44 |
|
|
2025
Q3 | $544K | Sell |
6,485
-60
| -0.9% | -$4.94K | 0.33% | 46 |
|
|
2025
Q2 | $518K | Sell |
6,545
-650
| -9% | -$51.7K | 0.33% | 44 |
|
|
2025
Q1 | $646K | Buy |
7,195
+130
| +2% | +$12.1K | 0.4% | 42 |
|
|
2024
Q4 | $703K | Hold |
7,065
| – | – | 0.47% | 40 |
|
|
2024
Q3 | $802K | Sell |
7,065
-290
| -4% | -$34.5K | 0.51% | 42 |
|
|
2024
Q2 | $911K | Hold |
7,355
| – | – | 0.64% | 38 |
|
|
2024
Q1 | $970K | Sell |
7,355
-10
| -0.1% | -$1.23K | 0.71% | 35 |
|
|
2023
Q4 | $803K | Sell |
7,365
-90
| -1% | -$9.34K | 0.61% | 36 |
|
|
2023
Q3 | $767K | Hold |
7,455
| – | – | 0.64% | 34 |
|
|
2023
Q2 | $860K | Hold |
7,455
| – | – | 0.79% | 34 |
|
|
2023
Q1 | $793K | Hold |
7,455
| – | – | 0.79% | 35 |
|
|
2022
Q4 | $827K | Hold |
7,455
| – | – | 0.9% | 33 |
|
|
2022
Q3 | $642K | Buy |
7,455
+120
| +2% | +$10.7K | 0.65% | 41 |
|
|
2022
Q2 | $669K | Sell |
7,335
-120
| -2% | -$10.6K | 0.64% | 36 |
|
|
2022
Q1 | $612K | Buy |
7,455
+180
| +2% | +$14.2K | 0.47% | 41 |
|
|
2021
Q4 | $558K | Buy |
+7,275
| New | +$579K | 0.49% | 37 |
|
|
2017
Q4 | – | Sell |
-44,111
| Closed | -$2.69M | – | 46 |
|
|
2017
Q3 | $2.69M | Sell |
44,111
-1,908
| -4% | -$116K | 2.67% | 17 |
|
|
2017
Q2 | $2.81M | Buy |
46,019
+5,226
| +13% | +$318K | 2.85% | 15 |
|
|
2017
Q1 | $2.47M | Sell |
40,793
-472
| -1% | -$28.6K | 2.77% | 21 |
|
|
2016
Q4 | $2.32M | Sell |
41,265
-12
| -0% | -$702 | 2.47% | 22 |
|
|
2016
Q3 | $2.46M | Sell |
41,277
-1,524
| -4% | -$89.1K | 2.96% | 13 |
|
|
2016
Q2 | $2.35M | Sell |
42,801
-137
| -0.3% | -$7.29K | 3.08% | 15 |
|
|
2016
Q1 | $2.17M | Sell |
42,938
-220
| -0.5% | -$10.8K | 3.13% | 13 |
|
|
2015
Q4 | $2.17M | Sell |
43,158
-744
| -2% | -$37.5K | 3.57% | 14 |
|
|
2015
Q3 | $2.07M | Buy |
43,902
+325
| +0.7% | +$17.3K | 2.98% | 19 |
|
|
2015
Q2 | $2.37M | Buy |
43,577
+179
| +0.4% | +$10K | 2.55% | 24 |
|
|
2015
Q1 | $2.38M | Buy |
+43,398
| New | +$2.46M | 2.64% | 23 |
|
|
2014
Q1 | – | Sell |
-2,835
| Closed | -$135K | – | 116 |
|
|
2013
Q4 | $135K | Buy |
+2,835
| New | +$130K | 0.13% | 54 |
|
Other funds holding MRK
VCM
VPM
Pring Turner Capital Group's MRK Position: Q1 2026 in Review
Pring Turner Capital Group held its Merck (MRK) position steady in Q1 2026 at 6,485 shares worth $683K. The position accounts for 0.41% of the portfolio, ranked #44.
Pring Turner Capital Group first reported a position in MRK in Q4 2013 and has held it in 30 quarters since. The position peaked at $2.81M in Q2 2017. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Pring Turner Capital Group held 6,485 shares of Merck worth $683K as of Q1 2026.
- Pring Turner Capital Group left its Merck share count unchanged in Q1 2026.
- Merck made up 0.41% of Pring Turner Capital Group's portfolio in Q1 2026, its #44 holding.
- Pring Turner Capital Group first reported a position in Merck in Q4 2013 and has held it in 30 quarters since.
- Pring Turner Capital Group's Merck position peaked at $2.81M in Q2 2017.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Pring Turner Capital Group's 13F filing for Q1 2026, filed 13 May 2026.